Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Biliary Tract Diseases

Free Subscription Articles published in PLoS One Retrieve available abstracts of 81 articles: HTML format

Single Articles

January 2022
1. SONGSERM N, Woradet S, Kankarn W, Pintakham K, et al
   Cholangiocarcinoma protective factors in Greater Mekong Subregion: Critical issues for joint planning to sustainably solve regional public health problems.
   PLoS One. 2022;17:e0262589.
   PubMed     Abstract available
   
   
   
2. LIU B, Zhang J, Shao L, Yao J, et al
   Network pharmacology analysis and molecular docking to unveil the potential mechanisms of San-Huang-Chai-Zhu formula treating cholestasis.
   PLoS One. 2022;17:e0264398.
   PubMed     Abstract available
   
   
   
3. YAMAMOTO Y, Sugimoto A, Maruo K, Tsujio G, et al
   CXCR2 signaling might have a tumor-suppressive role in patients with cholangiocarcinoma.
   PLoS One. 2022;17:e0266027.
   PubMed     Abstract available
   
   
   
4. LEE TW, Bae W, Kim S, Choi J, et al
   Incidence, risk factors, and prognosis of acute kidney injury in hospitalized patients with acute cholangitis.
   PLoS One. 2022;17:e0267023.
   PubMed     Abstract available
   
   
   
5. SONG J, Lei X, Lin H, Dai H, et al
   Predictive model for the intraoperative unresectability of hilar cholangiocarcinoma: Reducing futile surgical exploration.
   PLoS One. 2022;17:e0258522.
   PubMed     Abstract available
   
   
   
6. KALOGEROPOULU SK, Lloyd EJ, Rauch H, Redtenbacher I, et al
   Chronic cholecystitis: Diagnostic and therapeutic insights from formerly bile-farmed Asiatic black bears (Ursus thibetanus).
   PLoS One. 2022;17:e0264391.
   PubMed     Abstract available
   
   
   
7. ISHII M, Itano O, Morinaga J, Shirakawa H, et al
   Potential efficacy of hepatic arterial infusion chemotherapy using gemcitabine, cisplatin, and 5-fluorouracil for intrahepatic cholangiocarcinoma.
   PLoS One. 2022;17:e0266707.
   PubMed     Abstract available
   
   
   
8. UDOMSINPRASERT W, Ungsudechachai T, Vejchapipat P, Poovorawan Y, et al
   Systemic cytokine profiles in biliary atresia.
   PLoS One. 2022;17:e0267363.
   PubMed     Abstract available
   
   
   
9. LI J, Cen W, Tong C, Wang L, et al
   Fangchinoline induces gallbladder cancer cell apoptosis by suppressing PI3K/Akt/XIAP axis.
   PLoS One. 2022;17:e0266738.
   PubMed     Abstract available
   
   
   
10. SANGSUWANNUKUL T, Supimon K, Chieochansin T, Choomee K, et al
    Antitumor activity of T cells secreting alphaCD133-alphaCD3 bispecific T-cell engager against cholangiocarcinoma.
    PLoS One. 2022;17:e0265773.
    PubMed     Abstract available
    
    
    
11. ZHANG G, Liu X, Jian A, Zheng K, et al
    CHST4 might promote the malignancy of cholangiocarcinoma.
    PLoS One. 2022;17:e0265069.
    PubMed     Abstract available
    
    
    
12. WANG J, Zhao Q, Chen B, Sun J, et al
    Risk factors for metabolic bone disease of prematurity: A meta-analysis.
    PLoS One. 2022;17:e0269180.
    PubMed     Abstract available
    
    
    
13. WANG GY, Garcia V, Lee J, Yanum J, et al
    Nrf2 deficiency causes hepatocyte dedifferentiation and reduced albumin production in an experimental extrahepatic cholestasis model.
    PLoS One. 2022;17:e0269383.
    PubMed     Abstract available
    
    
    
14. XU W, Zhang M, Liu L, Yin M, et al
    Association of mucin family members with prognostic significance in pancreatic cancer patients: A meta-analysis.
    PLoS One. 2022;17:e0269612.
    PubMed     Abstract available
    
    
    
15. JIANG Y, Zhang Y, Yang Q, Zeng D, et al
    The association between fetal fraction and pregnancy-related complications among Chinese population.
    PLoS One. 2022;17:e0271219.
    PubMed     Abstract available
    
    
    
16. RICHTER B, Sanger C, Mussbach F, Scheuerlein H, et al
    Species specific morphological alterations in liver tissue after biliary occlusion in rat and mouse: Similar but different.
    PLoS One. 2022;17:e0271975.
    PubMed     Abstract available
    
    
    January 2021
17. FENG J, Wu R, Zhang G, Yang Z, et al
    Prognostic importance of numbers of retrieved lymph nodes and positive lymph nodes for ampulla of vater cancer (AVC) in 2347 patients from the Surveillance, Epidemiology, and End Results (SEER) database.
    PLoS One. 2021;16:e0244987.
    PubMed     Abstract available
    
    
    
18. CHA HJ, Hwang J, Lee LE, Park Y, et al
    The significance of cytoplasmic antinuclear antibody patterns in autoimmune liver disease.
    PLoS One. 2021;16:e0244950.
    PubMed     Abstract available
    
    
    
19. TAYLOR SA, Chen SY, Gadhvi G, Feng L, et al
    Transcriptional profiling of pediatric cholestatic livers identifies three distinct macrophage populations.
    PLoS One. 2021;16:e0244743.
    PubMed     Abstract available
    
    
    
20. NOGUCHI D, Kuriyama N, Nakagawa Y, Maeda K, et al
    The prognostic impact of lymphocyte-to-C-reactive protein score in patients undergoing surgical resection for intrahepatic cholangiocarcinoma: A comparative study of major representative inflammatory / immunonutritional markers.
    PLoS One. 2021;16:e0245946.
    PubMed     Abstract available
    
    
    
21. YASUKAWA K, Shimizu A, Motoyama H, Kubota K, et al
    Applicability of sentinel lymph node oriented treatment strategy for gallbladder cancer.
    PLoS One. 2021;16:e0247079.
    PubMed     Abstract available
    
    
    
22. THANEE M, Dokduang H, Kittirat Y, Phetcharaburanin J, et al
    CD44 modulates metabolic pathways and altered ROS-mediated Akt signal promoting cholangiocarcinoma progression.
    PLoS One. 2021;16:e0245871.
    PubMed     Abstract available
    
    
    
23. KOVAC JD, Dakovic M, Jankovic A, Mitrovic M, et al
    The role of quantitative diffusion-weighted imaging in characterization of hypovascular liver lesions: A prospective comparison of intravoxel incoherent motion derived parameters and apparent diffusion coefficient.
    PLoS One. 2021;16:e0247301.
    PubMed     Abstract available
    
    
    
24. PARK JW, Jeong JM, Cho KS, Cho SY, et al
    MiR-30a and miR-200c differentiate cholangiocarcinomas from gastrointestinal cancer liver metastases.
    PLoS One. 2021;16:e0250083.
    PubMed     Abstract available
    
    
    
25. SO H, Oh CH, Song TJ, Ko SW, et al
    Predictors of stent dysfunction in patients with bilateral metal stents for malignant hilar obstruction.
    PLoS One. 2021;16:e0249096.
    PubMed     Abstract available
    
    
    
26. MIHARA K, Matsuda S, Nakamura Y, Aiura K, et al
    Intraoperative laparoscopic detection of sentinel lymph nodes with indocyanine green and superparamagnetic iron oxide in a swine gallbladder cancer model.
    PLoS One. 2021;16:e0248531.
    PubMed     Abstract available
    
    
    
27. TANG W, Qiu JG, Deng X, Liu SS, et al
    Minimally invasive versus open radical resection surgery for hilar cholangiocarcinoma: Comparable outcomes associated with advantages of minimal invasiveness.
    PLoS One. 2021;16:e0248534.
    PubMed     Abstract available
    
    
    
28. SAAB M, Mestivier D, Sohrabi M, Rodriguez C, et al
    Characterization of biliary microbiota dysbiosis in extrahepatic cholangiocarcinoma.
    PLoS One. 2021;16:e0247798.
    PubMed     Abstract available
    
    
    
29. KIM MU, Lee Y, Lee JH, Cho SB, et al
    Predictive factors affecting percutaneous drainage duration in the percutaneous treatment of common bile duct stones.
    PLoS One. 2021;16:e0248003.
    PubMed     Abstract available
    
    
    
30. TAKADA N, Sugano H, Shirai Y, Saito N, et al
    Nafamostat mesilate, a nuclear factor kappa B inhibitor, enhances the antitumor action of radiotherapy on gallbladder cancer cells.
    PLoS One. 2021;16:e0257019.
    PubMed     Abstract available
    
    
    
31. KOH M, Park JH, Yoo C, Yoon SM, et al
    Radiation therapy for recurrent extrahepatic bile duct cancer.
    PLoS One. 2021;16:e0253285.
    PubMed     Abstract available
    
    
    
32. LENDVAI G, Szekerczes T, Illyes I, Csengeri M, et al
    Autophagy activity in cholangiocarcinoma is associated with anatomical localization of the tumor.
    PLoS One. 2021;16:e0253065.
    PubMed     Abstract available
    
    
    
33. CHUNG HG, Chang JI, Lee KH, Park JK, et al
    Comparison of EUS and ERCP-guided tissue sampling in suspected biliary stricture.
    PLoS One. 2021;16:e0258887.
    PubMed     Abstract available
    
    
    
34. MARINI TJ, Oppenheimer DC, Baran TM, Rubens DJ, et al
    Testing telediagnostic right upper quadrant abdominal ultrasound in Peru: A new horizon in expanding access to imaging in rural and underserved areas.
    PLoS One. 2021;16:e0255919.
    PubMed     Abstract available
    
    
    
35. POOSEKEAW P, Pairojkul C, Sripa B, Sa Ngiamwibool P, et al
    Adaptor protein XB130 regulates the aggressiveness of cholangiocarcinoma.
    PLoS One. 2021;16:e0259075.
    PubMed     Abstract available
    
    
    
36. KOKAS B, Szijarto A, Farkas N, Ujvary M, et al
    Percutaneous transhepatic drainage is safe and effective in biliary obstruction-A single-center experience of 599 patients.
    PLoS One. 2021;16:e0260223.
    PubMed     Abstract available
    
    
    January 2020
37. TSUKUDA S, Ikeura T, Ito T, Nakamaru K, et al
    Clinical implications of elevated serum interleukin-6 in IgG4-related disease.
    PLoS One. 2020;15:e0227479.
    PubMed     Abstract available
    
    
    
38. AKARA-AMORNTHUM P, Lomphithak T, Choksi S, Tohtong R, et al
    Key necroptotic proteins are required for Smac mimetic-mediated sensitization of cholangiocarcinoma cells to TNF-alpha and chemotherapeutic gemcitabine-induced necroptosis.
    PLoS One. 2020;15:e0227454.
    PubMed     Abstract available
    
    
    
39. ARTHUIS C, Diguisto C, Lorphelin H, Dochez V, et al
    Perinatal outcomes of intrahepatic cholestasis during pregnancy: An 8-year case-control study.
    PLoS One. 2020;15:e0228213.
    PubMed     Abstract available
    
    
    
40. HAHN F, Muller L, Mahringer-Kunz A, Schotten S, et al
    Risk prediction in intrahepatic cholangiocarcinoma: Direct comparison of the MEGNA score and the 8th edition of the UICC/AJCC Cancer staging system.
    PLoS One. 2020;15:e0228501.
    PubMed     Abstract available
    
    
    
41. KE Q, Lin N, Deng M, Wang L, et al
    The effect of adjuvant therapy for patients with intrahepatic cholangiocarcinoma after surgical resection: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0229292.
    PubMed     Abstract available
    
    
    
42. YOO YJ, Kang CM, Choi M, Rho SY, et al
    Preoperative prognostic nutritional index as an independent prognostic factor for resected ampulla of Vater cancer.
    PLoS One. 2020;15:e0229597.
    PubMed     Abstract available
    
    
    
43. LIN SY, Lin CL, Hsu WH, Wang IK, et al
    Risk of biliary tract disease in living liver donors: A population-based cohort study.
    PLoS One. 2020;15:e0230840.
    PubMed     Abstract available
    
    
    
44. SO AR, Si JM, Lopez D, Pellegrini M, et al
    Molecular signatures for inflammation vary across cancer types and correlate significantly with tumor stage, sex and vital status of patients.
    PLoS One. 2020;15:e0221545.
    PubMed     Abstract available
    
    
    
45. MIYAZAWA M, Takatori H, Kawaguchi K, Kitamura K, et al
    Management of biliary stricture in patients with IgG4-related sclerosing cholangitis.
    PLoS One. 2020;15:e0232089.
    PubMed     Abstract available
    
    
    
46. CHOU CK, Lee KC, Luo JC, Chen TS, et al
    Endoscopic papillary balloon dilatation less than three minutes for biliary stone removal increases the risk of post-ERCP pancreatitis.
    PLoS One. 2020;15:e0233388.
    PubMed     Abstract available
    
    
    
47. LU JJ, Li P, Yang Y, Wang L, et al
    Prognostic value of LAT-1 status in solid cancer: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0233629.
    PubMed     Abstract available
    
    
    
48. WU R, Zhang G, Feng J, Zhang L, et al
    Proposal of the optimal numbers of examined and positive lymph nodes to the 8th edition of American Joint Committee on Cancer (AJCC) staging for 758 patients with distal cholangiocarcinoma.
    PLoS One. 2020;15:e0234464.
    PubMed     Abstract available
    
    
    
49. KE Q, Chen Y, Huang Q, Lin N, et al
    Does additional resection of a positive microscopic ductal margin benefit patients with perihilar cholangiocarcinoma: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0232590.
    PubMed     Abstract available
    
    
    
50. RANIERI V, Kennedy E, Walmsley M, Thorburn D, et al
    The Primary Sclerosing Cholangitis (PSC) Wellbeing Study: Understanding psychological distress in those living with PSC and those who support them.
    PLoS One. 2020;15:e0234624.
    PubMed     Abstract available
    
    
    
51. ZIZALOVA K, Vecka M, Vitek L, Lenicek M, et al
    Enzymatic methods may underestimate the total serum bile acid concentration.
    PLoS One. 2020;15:e0236372.
    PubMed     Abstract available
    
    
    
52. TASKIN OC, Basturk O, Reid MD, Dursun N, et al
    Gallbladder polyps: Correlation of size and clinicopathologic characteristics based on updated definitions.
    PLoS One. 2020;15:e0237979.
    PubMed     Abstract available
    
    
    
53. CHANG TT, Ho CH
    Plasma proteome atlas for differentiating tumor stage and post-surgical prognosis of hepatocellular carcinoma and cholangiocarcinoma.
    PLoS One. 2020;15:e0238251.
    PubMed     Abstract available
    
    
    
54. HAYASHI M, Abe K, Fujita M, Takahashi A, et al
    Association between serum ficolin-1 level and disease progression in primary biliary cholangitis.
    PLoS One. 2020;15:e0238300.
    PubMed     Abstract available
    
    
    
55. KOJIMA T, Umeda Y, Fuji T, Niguma T, et al
    Efficacy of surgical management for recurrent intrahepatic cholangiocarcinoma: A multi-institutional study by the Okayama Study Group of HBP surgery.
    PLoS One. 2020;15:e0238392.
    PubMed     Abstract available
    
    
    
56. FUJIWARA K, Masatsugu T, Abe A, Hirano T, et al
    Preoperative diagnoses and identification rates of unexpected gallbladder cancer.
    PLoS One. 2020;15:e0239178.
    PubMed     Abstract available
    
    
    
57. SUN R, Zhao N, Zhao K, Su Z, et al
    Comparison of efficacy and safety of laparoscopic excision and open operation in children with choledochal cysts: A systematic review and update meta-analysis.
    PLoS One. 2020;15:e0239857.
    PubMed     Abstract available
    
    
    
58. THOMSEN H, Li X, Sundquist K, Sundquist J, et al
    Familial associations between autoimmune hepatitis and primary biliary cholangitis and other autoimmune diseases.
    PLoS One. 2020;15:e0240794.
    PubMed     Abstract available
    
    
    
59. KIM TH, Park DE, Chon HK
    Endoscopic transpapillary gallbladder drainage for the management of acute calculus cholecystitis patients unfit for urgent cholecystectomy.
    PLoS One. 2020;15:e0240219.
    PubMed     Abstract available
    
    
    
60. FENG L, Dong K, Zhang X, Ma B, et al
    Clinical significance of IgG antimitochondrial M2 antibody levels in primary biliary cholangitis: A single center study from China.
    PLoS One. 2020;15:e0242164.
    PubMed     Abstract available
    
    
    
61. SHIN J, Wood LD, Hruban RH, Hong SM, et al
    Desmin and CD31 immunolabeling for detecting venous invasion of the pancreatobiliary tract cancers.
    PLoS One. 2020;15:e0242571.
    PubMed     Abstract available
    
    
    
62. CHIU TJ, Chen YJ, Kuo FY, Chen YY, et al
    Elevated neutrophil-to-lymphocyte ratio and predominance of intrahepatic cholangiocarcinoma prediction of poor hepatectomy outcomes in patients with combined hepatocellular-cholangiocarcinoma.
    PLoS One. 2020;15:e0240791.
    PubMed     Abstract available
    
    
    
63. MOLE DJ, Fallowfield JA, Sherif AE, Kendall T, et al
    Quantitative magnetic resonance imaging predicts individual future liver performance after liver resection for cancer.
    PLoS One. 2020;15:e0238568.
    PubMed     Abstract available
    
    
    
64. JAFFEY JA, Matheson J, Shumway K, Pacholec C, et al
    Serum 25-hydroxyvitamin D concentrations in dogs with gallbladder mucocele.
    PLoS One. 2020;15:e0244102.
    PubMed     Abstract available
    
    
    January 2019
65. DI MATTEO S, Nevi L, Costantini D, Overi D, et al
    The FXR agonist obeticholic acid inhibits the cancerogenic potential of human cholangiocarcinoma.
    PLoS One. 2019;14:e0210077.
    PubMed     Abstract available
    
    
    
66. KOBAYASHI M, Ryozawa S, Iwano H, Araki R, et al
    The usefulness of wire-guided endoscopic snare papillectomy for tumors of the major duodenal papilla.
    PLoS One. 2019;14:e0211019.
    PubMed     Abstract available
    
    
    
67. KEIL R, Drabek J, Lochmannova J, Stovicek J, et al
    ERCP in infants, children, and adolescents-Different roles of the methods in different age groups.
    PLoS One. 2019;14:e0210805.
    PubMed     Abstract available
    
    
    
68. ABURAWI EH, Al Hamad S, Yasin J, Almekhaini LA, et al
    Dyslipidemia, subclinical inflammation, hepatic cholestasis and endothelial dysfunction in schoolchildren with excess fat: A study from the United Arab Emirates.
    PLoS One. 2019;14:e0210316.
    PubMed     Abstract available
    
    
    
69. LOOSEN SH, Lurje G, Wiltberger G, Vucur M, et al
    Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma.
    PLoS One. 2019;14:e0210944.
    PubMed     Abstract available
    
    
    
70. MISZCZUK GS, Banales JM, Zucchetti AE, Pisani GB, et al
    Adaptive downregulation of Cl-/HCO3- exchange activity in rat hepatocytes under experimental obstructive cholestasis.
    PLoS One. 2019;14:e0212215.
    PubMed     Abstract available
    
    
    
71. PARK DW, Lee YJ, Chang W, Park JH, et al
    Diagnostic performance of a point shear wave elastography (pSWE) for hepatic fibrosis in patients with autoimmune liver disease.
    PLoS One. 2019;14:e0212771.
    PubMed     Abstract available
    
    
    
72. MOSHER V, Swain M, Pang J, Kaplan G, et al
    Primary biliary cholangitis patients exhibit MRI changes in structure and function of interoceptive brain regions.
    PLoS One. 2019;14:e0211906.
    PubMed     Abstract available
    
    
    
73. KIM HS, Cho SK, Kim CS, Park JS, et al
    Big data and analysis of risk factors for gallbladder disease in the young generation of Korea.
    PLoS One. 2019;14:e0211480.
    PubMed     Abstract available
    
    
    
74. AICHER KM, Cullen JM, Seiler GS, Lunn KF, et al
    Investigation of adrenal and thyroid gland dysfunction in dogs with ultrasonographic diagnosis of gallbladder mucocele formation.
    PLoS One. 2019;14:e0212638.
    PubMed     Abstract available
    
    
    
75. PROMRAKSA B, Phetcharaburanin J, Namwat N, Techasen A, et al
    Evaluation of anticancer potential of Thai medicinal herb extracts against cholangiocarcinoma cell lines.
    PLoS One. 2019;14:e0216721.
    PubMed     Abstract available
    
    
    
76. PENG CH, Lee HC, Jiang CB, Hsu CK, et al
    Serum vitamin D level is inversely associated with liver fibrosis in post Kasai's portoenterostomy biliary atresia patients living with native liver.
    PLoS One. 2019;14:e0218896.
    PubMed     Abstract available
    
    
    
77. PANG S, Ding T, Qiao S, Meng F, et al
    A novel YOLOv3-arch model for identifying cholelithiasis and classifying gallstones on CT images.
    PLoS One. 2019;14:e0217647.
    PubMed     Abstract available
    
    
    
78. MORIS D, Kostakis ID, Machairas N, Prodromidou A, et al
    Comparison between liver transplantation and resection for hilar cholangiocarcinoma: A systematic review and meta-analysis.
    PLoS One. 2019;14:e0220527.
    PubMed     Abstract available
    
    
    
79. PANG S, Wang S, Rodriguez-Paton A, Li P, et al
    An artificial intelligent diagnostic system on mobile Android terminals for cholelithiasis by lightweight convolutional neural network.
    PLoS One. 2019;14:e0221720.
    PubMed     Abstract available
    
    
    
80. MIYAMOTO T, Ebihara T, Kozaki K
    The association between eating difficulties and biliary sludge in the gallbladder in older adults with advanced dementia, at end of life.
    PLoS One. 2019;14:e0219538.
    PubMed     Abstract available
    
    
    
81. DUANGKUMPHA K, Stoll T, Phetcharaburanin J, Yongvanit P, et al
    Urine proteomics study reveals potential biomarkers for the differential diagnosis of cholangiocarcinoma and periductal fibrosis.
    PLoS One. 2019;14:e0221024.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Biliary Tract Diseases is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: